Idera Extends Gains

Shares of Idera Pharmaceuticals Inc. (Nasdaq: IDRA) continued climbing by soaring 55 cents to $300 after Baker Bros. Advisors acquired 4.5 million shares of the biotech.

Related Stocks:
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here